Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one ...

About 58% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

Clinical efficacy was evaluated using the Psoriasis Area and Severity Index (PASI), along with metabolic indicators such as ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The following is a summary of “Treatment of plaque psoriasis with guselkumab reduces systemic inflammatory burden as measured by neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and ...

Patanjali Ayurved has achieved another milestone that could lead to a major breakthrough in the treatment of 'psoriasis', a ...

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

Patanjali Ayurved's research, published in the Journal of Inflammation Research, reveals promising results for their ...

Managing psoriasis is more than going to your doctor's appointments. Learn from experts on how to improve your self-care.

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a dive ...